Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system
Objective: The aim of this study was to evaluate the effectiveness of plants used in the formulations of traditional Chinese medicine (TCM), which were also used in clinical trials to treat patients with the novel coronavirus COVID-19, and to assess their effects on the cardiovascular system. Methods: A literature review of PubMed, ResearchGate, ScienceDirect, the Cochrane Library, and TCM monographs was conducted and the effects of the plants on the cardiovascular system and the mechanisms of action in COVID-19 treatment were evaluated. Results: The mechanism of action, cardiovascular effects, and possible toxicity of 10 plants frequently found in TCM formulations that were used in the clinical treatment of COVID-19 were examined. Conclusion: TCM formulations that had been originally developed for earlier viral diseases have been used in COVID-19 treatment. Despite the effectiveness seen in laboratory and animal studies with the most commonly used plants in these formulations, the clinical studies are currently insufficient according to standard operating procedures. More clinical studies are needed to understand the safe clinical use of traditional plants..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Türk Kardiyoloji Derneği Arşivi - 48(2020), 4, Seite 410-424 |
| Sprache: |
Englisch ; Türkisch |
|---|
| Beteiligte Personen: |
Emine Akalın [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Antiviral |
|---|
| doi: |
10.5543/tkda.2020.03374 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ055016294 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ055016294 | ||
| 003 | DE-627 | ||
| 005 | 20230310182130.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5543/tkda.2020.03374 |2 doi | |
| 035 | |a (DE-627)DOAJ055016294 | ||
| 035 | |a (DE-599)DOAJd20ba693f4e24f9eade127f081411774 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a tur | ||
| 050 | 0 | |a RC31-1245 | |
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Emine Akalın |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective: The aim of this study was to evaluate the effectiveness of plants used in the formulations of traditional Chinese medicine (TCM), which were also used in clinical trials to treat patients with the novel coronavirus COVID-19, and to assess their effects on the cardiovascular system. Methods: A literature review of PubMed, ResearchGate, ScienceDirect, the Cochrane Library, and TCM monographs was conducted and the effects of the plants on the cardiovascular system and the mechanisms of action in COVID-19 treatment were evaluated. Results: The mechanism of action, cardiovascular effects, and possible toxicity of 10 plants frequently found in TCM formulations that were used in the clinical treatment of COVID-19 were examined. Conclusion: TCM formulations that had been originally developed for earlier viral diseases have been used in COVID-19 treatment. Despite the effectiveness seen in laboratory and animal studies with the most commonly used plants in these formulations, the clinical studies are currently insufficient according to standard operating procedures. More clinical studies are needed to understand the safe clinical use of traditional plants. | ||
| 650 | 4 | |a antiviral | |
| 650 | 4 | |a cardiovascular system; covid-19; immunomodulator; traditional chinese medicine. | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Internal medicine | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Miraç Ekici |e verfasserin |4 aut | |
| 700 | 0 | |a Zinar Alan |e verfasserin |4 aut | |
| 700 | 0 | |a Elif Özbir Elevli |e verfasserin |4 aut | |
| 700 | 0 | |a Aysenur Yaman Bucak |e verfasserin |4 aut | |
| 700 | 0 | |a Nuerbiye Aobuliaikemu |e verfasserin |4 aut | |
| 700 | 0 | |a Ali Yağız Üresin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Türk Kardiyoloji Derneği Arşivi |d KARE Publishing, 2018 |g 48(2020), 4, Seite 410-424 |w (DE-627)DOAJ000073709 |x 10165169 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:4 |g pages:410-424 |
| 856 | 4 | 0 | |u https://doi.org/10.5543/tkda.2020.03374 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d20ba693f4e24f9eade127f081411774 |z kostenfrei |
| 856 | 4 | 0 | |u https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-03374 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1016-5169 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 4 |h 410-424 | ||